In Brief
How Smoothened localizes to primary cilia and is activated is poorly understood. Raleigh et al. find that cilia contain oxysterol lipids that bind to Smoothened and activate the Hedgehog pathway. Moreover, they identify an enzyme involved in cilia-associated oxysterol biosynthesis that is enriched in Hedgehog pathway-associated medulloblastoma and that blocking this enzyme using a compound in black licorice inhibits tumor growth.
INTRODUCTION
Hedgehog proteins control developmental patterning and tissue homeostasis in evolutionarily diverse organisms (Briscoe and Thé rond, 2013) . Misactivation of the Hedgehog (HH) pathway can lead to cancers, including medulloblastoma, the most common pediatric brain tumor, and basal cell carcinoma, the most common tumor in the United States. In vertebrates, HH signaling requires the primary cilium, an antenna-like projection on the surface of most cells. HH ligands relieve Patched1 (PTCH1) repression of Smoothened (SMO), allowing SMO to accumulate in cilia and activate GLI transcription factors (Briscoe and Thé rond, 2013) . How SMO accumulates in cilia and is activated is incompletely understood.
Sterol lipids are required for vertebrate HH signaling, and both synthetic oxysterols and cholesterol can bind SMO to activate the downstream pathway Cooper et al., 2003; Corcoran and Scott, 2006; Dwyer et al., 2007; Huang et al., 2016 Huang et al., , 2018 Luchetti et al., 2016; Myers et al., 2013 Myers et al., , 2017 Nachtergaele et al., 2012 Nachtergaele et al., , 2013 Nedelcu et al., 2013; Xiao et al., 2017) . Synthetic oxysterols bind to the SMO N-terminal extracellular cysteine-rich domain (CRD), cause SMO to accumulate in cilia, activate the HH pathway, and stimulate the growth of cultured medulloblastoma cells (Corcoran and Scott, 2006; Dwyer et al., 2007; Myers et al., 2013; Nachtergaele et al., 2013; 2012; Nedelcu et al., 2013) . Similarly, cholesterol binds to the SMO CRD and can induce HH signaling in neural progenitors, leading to the hypothesis that cholesterol is the endogenous ligand that activates SMO Huang et al., 2016 Huang et al., , 2018 Luchetti et al., 2016) . Phosphatidylinositol 4-phosphate is enriched in the ciliary membrane, revealing that the primary cilium can have a lipid composition distinct from that of other cellular membranes (Chá vez et al., 2015; Garcia-Gonzalo et al., 2015) . Therefore, we hypothesized that oxysterols that activate SMO may be present in primary cilia and may stimulate the HH pathway specifically in this subcellular context.
To define the oxysterol composition of cilia, we performed mass spectrometry of the membranes of isolated cilia. We identified endogenous cilia-associated oxysterols that bind SMO, cause SMO to accumulate in cilia, and activate the HH pathway. Moreover, we found that cilia-associated oxysterols activate the HH pathway through two separate domains of SMO. Either genetic or pharmacologic inhibition of HSD11b2, an oxysterol synthase, attenuates HH signal transduction and the growth of HH pathway-associated medulloblastoma. Thus, oxysterols found in primary cilia bind two distinct domains of SMO, cause SMO to accumulate in cilia, and activate the HH pathway to promote the growth of medulloblastoma.
RESULTS

Identification of Cilia-Associated Oxysterols
To identify ciliary oxysterols, we biochemically isolated cilia from sea urchin (Strongylocentrotus purpuratus) embryos, which require cilia to transduce HH signals (Figures 1A and 1B; Sigg et al., 2017; Warner et al., 2014) . High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) with normalization to protein content revealed that sea urchin embryo cilia are enriched in 7-keto-cholesterol (7k-C), 7b,27-dihydroxycholesterol (7b,27-DHC), 24-keto-cholesterol (24k-C), and 24,25-epoxycholesterol (24,25-EC) compared to either whole and de-ciliated embryos ( Figures 1C, S1A , and S1B).
Cilia-Associated Oxysterols Bind to SMO, Activate the Hedgehog Pathway, and Cause SMO to Accumulate in Cilia 7k-C does not activate the HH pathway (Dwyer et al., 2007) . As the other oxysterols that were enriched in sea urchin embryo cilia had not been previously investigated for roles in HH signaling, we examined whether they were able to bind to SMO. We incubated detergent-solubilized membranes from HEK293S cells expressing SMO with 20(S)-yne affinity resin and oxysterol competitors. Both 7b,27-DHC and 24(S),25-EC competed with 20(S)-OHC for occupancy of the CRD, demonstrating that 7b,27-DHC and 24(S),25-EC bind to SMO ( Figure 1D ).
Treating ciliated NIH/3T3 cells with 7b,27-DHC and 24(S),25-EC showed that both can activate the HH pathway in a dose-dependent manner ( Figures 1E-1H ). Moreover, 7b,27-DHC and 24(S),25-EC synergized with one another to activate the HH pathway, suggesting that cilia-associated oxysterols may activate the HH pathway through multiple effectors or multiple domains within a single effector ( Figure 1I ).
Synthetic oxysterols and cholesterol require the SMO CRD to activate the HH pathway (Huang et al., 2016; Luchetti et al., 2016; Myers et al., 2013) . To determine whether the SMO CRD is also necessary for cilia-associated oxysterols to activate the HH pathway, we co-transfected ciliated Smo À/À mouse embryonic fibroblasts (MEFs) with a HH pathway luciferase reporter and SMO or SMO lacking the CRD (SMODCRD) and treated the cells with vehicle, 7b,27-DHC, 24k-C, or 24(S),25-EC. Similar to synthetic oxysterols and cholesterol, 7b,27-DHC was unable to activate the HH pathway through SMODCRD ( Figure 1J ). In contrast, 24k-C and 24(S),25-EC were able to activate the pathway through SMODCRD, albeit to a reduced extent, suggesting that these two oxysterols can function independently of the CRD through another domain of SMO ( Figure 1K ). Similar to 24k-C and 24(S),25-EC, Sonic Hedgehog (SHH) activated the HH pathway through SMODCRD to a reduced extent ( Figure 1J ). Together, these data indicate that 7b,27-DHC, 24k-C, and 24(S),25-EC are cilia-associated oxysterols capable of activating SMO.
To test whether any cilia-associated oxysterols promote the accumulation of SMO in cilia, we generated NIH/3T3 cell lines stably expressing EGFP fusions of wild-type SMO or SMO with the Y134F substitution (SMO Y134F ), which abolishes oxysterol interaction with the CRD (Nachtergaele et al., 2013) . Quantification of ciliary immunofluorescence revealed that 7b,27-DHC, which requires the CRD to activate the HH pathway ( Figure 1J ), and 24(S),25-EC, which does not require the CRD ( Figure 1K ), both induced accumulation of SMO-EGFP in cilia ( Figures 1L, 1M , and S2A). 7b,27-DHC did not cause SMO Y134F -EGFP to accumulate in cilia ( Figures 1L and S2A ). In contrast, 24(S),25-EC caused SMO Y134F -EGFP to accumulate in cilia, consistent with the ability of this oxysterol to activate the HH pathway independent of the SMO CRD ( Figures 1M and S2A) . Thus, 7b,27-DHC and 24(S),25-EC are oxysterols that are present in cilia and can promote the accumulation of SMO in cilia and activation of the HH pathway through distinct mechanisms.
Cilia-Associated Oxysterols Activate the HH Pathway through Separate SMO Domains Although the SMO CRD is critical for 7b,27-DHC to activate SMO, the dispensability of the CRD for SMO activation by 24k-C and 24(S),25-EC raises the possibility that other domains of SMO may interact with oxysterols. Apart from the CRD, vertebrate SMO contains a site within the transmembrane domains of the heptahelical bundle (HHB) that binds small molecules, such as cyclopamine (CYA) (Chen et al., 2002a (Chen et al., , 2002b . In addition, certain B-ring oxysterols can inhibit SMO at a site distinct from either the CRD or the HHB (Chen et al., 2002a; Sever et al., 2016) , raising the possibility that there is another site within SMO that interacts with 24k-C and 24(S),25-EC.
To probe whether a cilia-associated oxysterol can bind to a domain of SMO other than the CRD, we synthesized 24k-C-BODIPY ( Figure S2B ) and assessed its ability to interact with recombinant SMO or SMODCRD by fluorescence polarization anisotropy. Either SMO or SMODCRD increased the polarization of CYA-BODIPY fluorescence, consistent with the ability of CYA to interact with either the CRD or the HHB (Figure 2A ; Chen et al., 2002a; Huang et al., 2016) . Consistently, CYA-BODIPY demonstrated positively cooperative binding to SMO (Hill coefficient 1.6), but not to SMODCRD (Hill coefficient 0.8), and the micromolar K d of CYA-BODIPY binding to SMO was four-fold lower than to SMODCRD Chen et al., 2002a) . Like CYA-BODIPY fluorescence polarization, 24k-C-BODIPY fluorescence polarization increased in the presence of SMO ( Figure 2B ). 24k-C-BODIPY fluorescence polarization also increased in the presence of SMODCRD with a K d equivalent to that for full-length SMO, indicating that 24k-C-BODIPY can bind to a domain of SMO other than the CRD. To identify possible oxysterol binding sites outside of the CRD, we computationally docked the oxysterols 24k-C and 24(S),25-EC in human SMO with 4Å relaxation of side chains to mimic induced fit. We identified a possible binding pocket comprised of cytoplasmic-facing portions of transmembrane domain 1 (TMD1) (T251-I266), TMD3 (W339-L346), TMD6 (N446-I454), and TMD7 (W535-T553; Figures 2C and 2D ). We named this site the cytoplasmic binding pocket (CBP). Within the CBP, modeling suggested that residues D255 and N446 in human SMO (corresponding to D259 and N450 in mouse SMO) could hydrogen bond with the carbon 3 hydroxyl and iso-octyl tail oxygens of 24k-C and 24(S),25-EC, respectively ( Figures 2E and 2F ). Therefore, we hypothesized that 24k-C and 24(S),25-EC activate SMO by binding to the CBP.
To test whether the CBP participates in oxysterol-mediated activation of SMO, we generated mutant forms of SMO with substitutions at either of the two residues predicted to hydrogen bond with oxysterols (D259R or N450D; Figure S2C Figure 2G ). In contrast, 24(S),25-EC activation of SMO Y134F , SMO D259R , and SMO N450D was less than wild-type SMO, suggesting that activation by 24(S),25-EC involves both the CRD and the CBP ( Figure 2G ). Further supporting the idea that the CRD and CBP have partly overlapping functions in promoting SMO activity, neither 7b,27-DHC nor 24(S),25-EC could activate SMO containing substitutions in both the CRD and CBP (SMO Y134F, D259R ; Figure 2G ). These data suggest that cilia-associated oxysterols activate SMO through both the CRD and CBP. -EGFP to accumulate in cilia, although to a lesser extent than wild-type SMO-EGFP ( Figure 2H ). 7b,27-DHC caused SMO D259R -EGFP and SMO N450D -EGFP to accumulate in cilia, but not SMO Y134F -EGFP, again consistent with 7b,27-DHC requiring the CRD to activate the HH pathway ( Figure 2H ). In contrast, 24(S),25-EC failed to induce ciliary accumulation of either SMO D259R -EGFP or SMO N450D -EGFP but did cause SMO Y134F -EGFP to accumulate in cilia, further suggesting that 24(S),25-EC activity is dependent on the CBP ( Figure 2H ). Combining substitutions that inhibit the function of both the CRD and the CBP (SMO Y134F, D259R ) abolished the ability of either 7b,27-DHC or 24(S),25-EC to promote ciliary accumulation (Figure 2H) . Together, these results suggest that 7b,27-DHC acts through the CRD, 24(S),25-EC primarily acts through the CBP, and the CRD and CBP have overlapping functions in promoting the ciliary accumulation of SMO in cilia. In further support of that hypothesis, ciliary accumulation of SMO D259R -EGFP,
-EGFP, and SMO Y134F -EGFP by SHH and SAG were diminished, and SHH failed to cause SMO Y134F, D259R -EGFP to accumulate in cilia ( Figure 2H ). SMO
W535L
, also called SMOM2, is a constitutively active, oncogenic form of SMO associated with HH pathway-associated medulloblastoma and basal cell carcinoma (Lam et al., 1999; Xie et al., 1998) . How the W535L substitution activates SMO is unknown. We discovered that W535 is located within the CBP, and modeling suggested that W535 may form van der Waals interactions with oxysterols ( Figure 2I ). To determine whether residues involved in oxysterol binding are necessary for SMOM2 activity, we expressed SMOM2, SMOM2 Y134F ,
Y134F and D259R substitutions reduced SMOM2 activity, and combined Y134F and D259R substitutions blocked SMOM2 activity, suggesting that the CRD and CBP are both important for oncogenic HH signaling by SMOM2 ( Figures 2J and S2D ).
To determine whether the CRD and CBP are important for ciliary accumulation of SMOM2, we generated stable NIH/3T3 distant from the CRD (red). Residues D255 and N446 (corresponding to D259 and N450 in mouse SMO) are predicted to form hydrogen bonds (dashed lines) with the carbon 3 hydroxyl and iso-octyl tail oxygens, respectively, of 24k-C (E) and 24(S),25-EC (F). Hydrogen bond lengths are shown in angstroms (Å ). -EGFP treated with vehicle (ethanol), 100 nM SAG, 1 mg/mL SHH, or 30 mM 7b,27-DHC or 24(S),25-EC. Data are from 2 separate cell lines normalized to the average intensity in cells expressing wild-type SMO-EGFP and treated with vehicle. Y134F substitution in the CRD specifically blocks the ability of 7b,27-DHC to induce SMO accumulation in cilia, whereas the D259R and N450D substitutions in the CBP block the effect 24(S),25-EC. Combined substitutions in the CRD and CBP block the effect of cilia-associated oxysterols and SHH and substantially attenuate the effect of SAG. lines expressing fusions of EGFP with SMOM2 or SMOM2 with combined Y134F and D259R substitutions. Consistent with the functional data, quantitative immunofluorescence showed that SMOM2 Y134F, D259R -EGFP failed to accumulate in cilia, indicating that the CRD and CBP are critical for mediating the constitutive ciliary localization of SMOM2 ( Figures 2K and S2E) . Thus, as with wild-type SMO, the CRD and CBP promote the ability of SMOM2 to activate the HH pathway.
The Oxysterol Synthase HSD11b2 Participates in SMOMediated Activation of the HH Pathway We hypothesized that enzymes involved in cilia-associated oxysterol biosynthesis would be enriched in domains of active HH signaling. To begin to test that hypothesis, we performed RNA sequencing of the mouse Math1-Cre SmoM2 c/WT model of HH-pathway-associated medulloblastoma, in which constitutively active SMOM2 is specifically expressed in the cerebellar external granule layer (EGL). Among the diverse oxysterol synthases expressed in medulloblastoma, hydroxysteroid 11-b dehydrogenase 2 (Hsd11b2) displayed the highest differential expression and was 864-± 82-fold higher in Math1-Cre SmoM2 c/WT medulloblastomas than in control cerebella (Figures 3A , S3A, and S3B). Similar to mouse medulloblastoma, HSD11b2 was also enriched in human HH pathway-associated medulloblastoma ( Figures 3B, S3C , and S3D).
During development, HSD11b2 is expressed in domains of active HH signaling, including the EGL (Heine and Rowitch, 2009 ; Ná ray-Fejes-Tó th and Fejes-Tó th, 2007). Given the developmental expression pattern of HSD11b2, and the finding that HSD11b2 is dramatically upregulated in HH pathway-associated medulloblastoma, we hypothesized that HSD11b2 could participate in the production of SMO-activating oxysterols.
PTCH1 represses the HH pathway upstream of SMO, whereas SUFU represses the HH pathway by binding to GLI transcription factors downstream of SMO (Briscoe and Thé rond, 2013 Figures 3D and 3E ). HSD11b2 is inhibited by a compound in licorice (Farese et al., 1991; Monder et al., 1989) . We hypothesized that carbenoxolone (CNX), a derivative of the HSD11b2 inhibitor in licorice, would block HH signaling by inhibiting oxysterol production. In support of that hypothesis, we found that CNX reduced HH pathway activity in a dose-dependent manner in Ptch1 À/À MEFs, but not Sufu À/À MEFs ( Figures 3F and 3G ).
To determine whether HSD11b2 regulates SMO, we expressed SMO or SMODCRD in ciliated Smo À/À MEFs, stimulated with SHH with or without HSD11b2 inhibition, and measured pathway activity. CNX inhibition of HSD11b2 reduced HH signaling through SMO but had no effect on signaling through SMODCRD, suggesting that HSD11b2 promotes the production of oxysterols that act through the CRD ( Figure 3H ). Competition assays with BODIPY-CYA demonstrated that CNX does not directly antagonize SMO at the CYA-binding pocket (Figures S3G and S3H) . Given that cilia-associated oxysterols can bind the CRD and induce SMO accumulation in cilia, we hypothesized that HSD11b2 would also regulate SMO accumulation in cilia. Indeed, in NIH/3T3 cells stimulated with either SHH or SAG, pharmacologic inhibition of HSD11b2 reduced the ciliary accumulation of SMO ( Figures 3J, 3K , and S3F). Together, these data indicate that HH signaling induces expression of HSD11b2, which promotes SMO activity through production of oxysterols that act at the CRD ( Figure 3L ).
HSD11b2 and CYP27A1 Participate in the Production of SMO-Activating Oxysterols
Overexpression of HSD11b2 in ciliated NIH/3T3 cells conferred resistance to CNX but did not activate the HH pathway (Figures S3I and S3J) . One interpretation of these data is that HSD11b2 generates a precursor molecule that requires downstream processing by a rate-limiting enzyme to activate SMO. 7k-C is present in sea urchin embryo cilia ( Figure 1C ), and we hypothesized that HSD11b2 converts 7b-OHC to 7k-C as a precursor for biosynthesis of 7-keto,27-hydroxycholesterol (7k,27-OHC) and 7b,27-DHC, both of which bind to SMO and promote SMO activity (Figure 4A ). To test whether HSD11b2 can generate 7k-C, we cultured HEK293T cells overexpressing HSD11b2 with 7b-OHC or the related oxysterol 7a-OHC and used HPLC-MS/MS to assess 7k-C production. HSD11b2 increased 7k-C production in 7b-OHC-treated cells, but not in 7a-OHC-treated cells ( Figure 4B ). 7k-C production in HEK293T cells overexpressing HSD11b2 was inhibited by CNX ( Figure 4B ), suggesting that HSD11b2 converts 7b-OHC to 7k-C.
To assess whether HSD11b2 participates in the production of cilia-associated oxysterols, we biochemically isolated cilia from pig (Sus scrofa) LLC-PK1 renal cells ( Figures 4C and 4D ), which express Hsd11b2 ( Figure S3K ). HPLC-MS/MS analysis revealed that LLC-PK1 cilia, like sea urchin cilia, were enriched in 7k-C (Figures 4E, S1C, and S1D). Pharmacologic inhibition of HSD11b2 reduced 7k-C in LLC-PK1 cells and cilia ( Figure 4E ), further indicating that HSD11b2 generates 7k-C.
To test the hypothesis that HSD11b2 converts 7b-OHC to 7k-C as a precursor for the biosynthesis of SMO-activating oxysterols, we cultured ciliated Ptch1 À/À MEFs in oxysterols and
Hsd11b2 shRNAs or CNX. Following genetic or pharmacologic inhibition of HSD11b2, the addition of 7k-C, 7b,27-DHC, and 7k,27-OHC restored HH pathway activity ( Figures 4F, 4G , and S3L). Thus, 7k-C, 7b,27-DHC, and 7k,27-OHC function downstream of HSD11b2 to activate the HH pathway. Sterol 27-hydroxylase (CYP27A1) converts 7k-C into 7k,27-OHC ( Figure 4H ; Heo et al., 2011) , and we hypothesized that CYP27A1 acts downstream of HSD11b2 to generate SMO-activating oxysterols. LLC-PK1 cells do not transduce HH signals and do not express Cyp27a1 ( Figure S3K ). However, expression of CYP27A1 in LLC-PK1 cells was sufficient to activate the HH transcriptional program, suggesting that absence of CYP27A1 limits the production of a SMO-activating oxysterol in LLC-PK1 cells ( Figure 4I ). Like HSD11b2, shRNA-mediated depletion of CYP27A1 inhibited HH pathway activity in Ptch1 À/À MEFs (Figures 4J and S3M ). 7b,27-DHC and 7k,27-OHC, but not 7k-C, restored HH signaling following depletion of CYP27A1 (Figure 4J) . Thus, CYP27A1 functions downstream of 7k-C in the pathway of SMO-activating oxysterol biosynthesis. A model that accounts for these data is that (1) HSD11b2 oxidizes 7b-OHC to 7k-C, (2) CYP27A1 oxidizes 7k-C to 7k,27-OHC, and (3) reactive oxygen species reduce 7k,27-OHC to 7b,27-DHC ( Figure 4K ). Both 7k,27-OHC and 7b,27-DHC bind to the CRD, cause SMO to accumulate in cilia, and induce HH pathway activity.
Oxysterol Biosynthesis Potentiates Cerebellar and Oncogenic HH Signaling
Hsd11b2 is strongly expressed in the neonatal cerebellum, raising the possibility that it participates in cerebellar development ( Figure 5A ; Pal et al., 2011) . To test that hypothesis, we conditionally deleted Hsd11b2 (Hsd11b2 mice are subviable (p = 0.01; chi-square test). HH signaling promotes EGL proliferation (Corrales et al., 2006) , and in mice surviving to P7, deletion of Hsd11b2 decreased EGL thickness and reduced cerebellar HH pathway activity ( Figures 5B-5D ). Using HPLC-MS/MS and SmoM2 c/WT cerebella, we found that 7k-C was elevated at P14, when the cerebellum is still developing (Figures 5E and S4 ). At P35, cerebellar 7k-C decreased, paralleling decreased Hsd11b2 expression ( Figures  5A and 5E ). Constitutive HH pathway activation in the EGL of HSD11b2 converts cortisol to cortisone in the kidney, raising the possibility that HSD11b2 promotes granule cell proliferation by metabolizing glucocorticoids (Heine and Rowitch, 2009 ). However, deletion of HSD11b2 in the cerebellum did not affect glucocorticoid target gene expression ( Figures S5A and S5B ), suggesting that HSD11b2 may not be critical for restraining physiological levels of glucocorticoids in the cerebellum. In further contrast to glucocorticoids, pharmacologic inhibition of HSD11b2 in vivo did not increase medulloblastoma apoptosis ( Figures S5C and S5D ).
In support of the possibility that oxysterol synthases producing SMO-activating ligands participate in pathogenic signaling, homozygous genetic deletion of Hsd11b2 from the EGL of the Math1-Cre SmoM2 c/WT mice reduced HH pathway activity in medulloblastoma ( Figure 5F ). Homozygous genetic deletion of Hsd11b2 also reduced tumor weight and the prevalence of small round blue cells characteristic of medulloblastoma, as well as partially restored cerebellar architecture ( Figures 5G-5I Figure 5J ). We hypothesized that, like genetic deletion of Hsd11b2, CNXmediated inhibition of HSD11b2 might inhibit the growth of HH pathway-associated cancer. Treatment of cultured basal cell carcinoma (ASZ) and medulloblastoma (Med1) cells with CNX reduced HH pathway activity ( Figures S5E and S5F ). Mass spectrometry confirmed that CNX crosses the blood brain barrier in vivo ( Figure S5G ; Heine and Rowitch, 2009 S5H , and S5I).
DISCUSSION
We have identified cilia-associated oxysterols that promote ciliary accumulation of SMO and activate the HH pathway through two separate domains of SMO. The CRD, an N-terminal extracellular domain, was previously identified as a site of action for synthetic oxysterols and cholesterol Nachtergaele et al., 2012 Nachtergaele et al., , 2013 Nedelcu et al., 2013) . The second site, the CBP, is at the membrane-cytoplasmic interface, and like the CRD, substitutions within the CBP abrogate SMO activity. HSD11b2, an oxysterol synthase expressed in regions of active HH signaling, participates in the production of SMOactivating oxysterols that activate the CRD. Consistently, we find that either genetic deletion of HSD11b2 or pharmacologic inhibition with a compound from licorice diminishes HH signal transduction and the growth of HH pathway-associated cancer. Recent structures of SMO with cholesterol or 20(S)-OHC in the CRD reveal interactions between the 3b-hydroxyl group of sterols and a SMO CRD aspartate (D99 in mouse SMO; Byrne et al., 2016; Huang et al., 2016 Huang et al., , 2018 Luchetti et al., 2016) . SMO D99 is essential for the ability of the CRD to bind sterols, indicating that CRD binding of the 3b-hydroxyl group of sterols is important for SMO activation (Huang et al., 2016; Nedelcu et al., 2013) . The 3b-hydroxyl group is also present in cilia-associated oxysterols, raising the possibility that cilia-associated oxysterols bind the CRD in a similar conformation. In the CBP, modeling and mutagenesis similarly suggest that interaction between the oxysterol 3b-hydroxyl group and SMO D259 are important for SMO activation.
Interestingly, W535, commonly mutated to L to oncogenic activate SMO, is located within the CBP (Xie et al., 1998) . How the W535L substitution constitutively activates SMOM2 is unknown. As the activity of SMOM2 depends on other CBP residues, we speculate that W535L induces a conformational change that mimics oxysterol binding. In support of the possibility that SMOM2 does not depend on oxysterol binding to the CBP, SMOM2 activity is independent of a cholesterol biosynthetic enzyme required for wild-type SMO activity (Blassberg et al., 2016) .
For an oxysterol to be a SMO agonist, it must be present in HH-responsive cells, it must bind and activate SMO, and it must be required for pathway activity. We have shown that 7b,27-DHC, 24k-C, and 24,25-EC are produced by sea urchin and mammalian cells and bind and activate SMO. Moreover, the contribution of HSD11b2 to oncogenic HH signaling suggests that the oxysterols produced by enzymes are required for high-level pathway activity, providing evidence that oxysterols are relevant endogenous SMO agonists.
We propose that the SMO CRD and CBP are activated through binding oxysterols. As SMO-activating oxysterols are enriched in the ciliary membrane, perhaps SMO only encounters its cognate oxysterols once it has accessed this specialized compartment. Alternatively, SMO may encounter oxysterols elsewhere where they induce a conformation that stimulates SMO accumulation in cilia. In either model, the involvement of oxysterols activating SMO through two sites is reminiscent of the ''two-person concept,'' which requires two operators to unlock separate locks to launch a missile, a system designed to increase the fidelity of critical decisions (Woodward, 2013) .
The ability of CNX to suppress medulloblastoma growth suggests that inhibiting oxysterol biosynthesis may be a useful approach to targeting HH pathway-associated cancers. Given the selective enrichment of HSD11b2 among molecular subgroups of medulloblastoma, we anticipate that oxysterol biosynthesis inhibition may only be useful for HH pathway-associated tumors. Indeed, the expression of HSD11b2 is highly cell-typespecific (Heine and Rowitch, 2009; Ná ray-Fejes-Tó th and Fejes-Tó th, 2007) . Therefore, inhibiting oxysterol synthases may be a strategy to inhibit the HH pathway in a tissue-specific manner, thereby lessening the toxicity of HH pathway inhibition that has limited the clinical utility of SMO antagonists in pediatric cancer patients (Lucas and Wright, 2016) .
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STAR+METHODS KEY RESOURCES TABLE
Chemistry
Reagents and solvents were purchased from Sigma-Aldrich and used as received unless otherwise indicated. A synthetic mechanism is diagramed in Figure S2B . Compound 1 was prepared as previously described (Windsor et al., 2013) . Flash column chromatography was carried out using a Biotage Isolera Four system and SiliaSep silica gel cartridges from Silicycle. 1H NMR spectra were recorded on a Varian INOVA-400 400MHz spectrometer. Chemical shifts are reported in d units ( 77, 121.70, 85.03, 72.94, 72.79, 71.82, 62.88, 62.73, 56.76, 55.81, 50.11, 42.35, 42.31, 39.79, 37.26, 36.51, 35.38, 35.36, 34.29, 34.22, 31.91, 31.68, 31.13, 31.01, 28.15, 24.28, 21.09, 19.42, 18.72, 18.67, 11.89 ; LCMS m/z 407.06 (MNa + ). To synthesize 24k-C-yne ( Figure S2B ), manganese (IV) oxide, activated (0.13 g, 1.5 mmol), was added to a solution of Compound 2 in tetrahydrofuran (2mL) and stirred at room temperature for 48 h. The reaction mixture was filtered through celite, the filtrate concentrated under reduced pressure and purified by flash column chromatography (0%-35% ethyl acetate/hexanes) to obtain 9 mg (31%) of 24k-C-yne as colorless oil.
1H NMR (400 MHz, CDCl3) d 5. 01, 140.76, 121.67, 78.28, 77.24, 71.81, 56.73, 55.74, 50.07, 42.53, 42.41, 42.30, 39.74, 37.26, 36.50, 35.20, 31.90, 31.66, 29.79, 28.11, 24.26, 21.08, 19.41, 18.42, 11.89 ; LCMS m/z 405.10 (MNa + ).
To synthesize 24k-C-BODIPY ( Figure S2B ), a solution of 0.3 M aqueous solution of copper(II) sulfate pentahydrate (4 mL, 0.0013 mmol) and 1M aqueous solution of sodium ascorbate (26 mL, 0.026) was added to a solution of BODIPY-FL-azide (5 mg, 0.013 mmol) and 24k-C-yne in N,N'-dimethylformamide/water (1 mL, 1:1). After stirring at 80 C for 18 h, the reaction mixture was diluted with dicholoromethane (5 mL). The organic layers were washed with brine, dried over magnesium sulfate, concentrated under reduced pressure and purified by flash column chromatography (0%-50% ethyl acetate/hexanes followed by 5% methanol/ dichloromethane) to obtain 6 mg (61%) of compound 4 as bright orange solid. 
Cilia Isolation
Gastrula stage Strongylocentrotus purpuratus embryos were concentrated by centrifugation at 170-200 x g for 4-10 min at 4 C and washed 3-4 times with artificial seawater. To isolate cilia, embryos were gently resuspended in 0.5M NaCl in artificial seawater approximately 10 times the volume of the embryo pellet. The samples were immediately centrifuged at 400 x g for 5 min at 4 C to pellet de-ciliated embryos. The supernatant was transferred to a fresh tube and centrifuged at 400 x g for another 5 min at 4 C to pellet any remaining embryos. The supernatant was then centrifuged at 10,000 x g for 20 min at 4 C and the cilia pellet was collected. LLC-PK1 cells were cultured for 3 weeks after confluence for ciliary elongation, and at least three 15-cm diameter plates were pooled for each treatment condition. Cells were washed in PBS, and cilia were isolated by shear force on a rotary shaker at 37 C for 4 min at 360 rotations per minute. Cell debris were removed by centrifugation at 4 C for 10 min at 1,000 x g, then cilia were isolated from the supernatant by ultracentrifugation at 4 C for 30 min at 40,000 x g (Mitchell, 2013) .
Immunofluorescence Cells on glass coverslips were washed in PBS and fixed in 4% paraformaldehyde for 8 min. Following incubation in blocking buffer for 30 min at room temperature (2.5% BSA, 0.1% Triton X-100 and 0.03% NaN 3 ), cells were incubated with primary antibodies in blocking buffer overnight at 4 C. The next day, cells were washed 3 times in PBS and incubated with secondary antibodies and DNA dyes in blocking buffer at room temperature for 1 hr. Following 3 final washes in PBS, coverslips were mounted with Gelvatol mounting media.
Luciferase Assays SHH Light II cells stably express a GLI-responsive Firefly luciferase reporter and pRL-TK (Promega, Madison, WI), which constitutively expresses Renilla luciferase. For other cell lines, pRL-TK and reporter constructs were transiently expressed using Lipofectamine LTX with Plus Reagent (Thermo Fisher Scientific). HH reporter activity was quantified from pGL3-Luciferase (Promega) containing 8 consecutive GLI binding sites. Luciferase assays with 1% control renilla construct (5 ng) and 99% reporter luciferase construct (495 ng) were performed 72 hr after transfection using the Dual Luciferase Reporter Assay System (Promega) and a GloMax 96 Microplate Luminometer with Dual Injectors (Promega). Firefly luciferase reporter activities were calculated relative to internal renilla luciferase controls.
Mass Spectrometry
For mass spectrometry of sea urchin samples, a modified fractionation method was used to enhance detection of dihydroxysterols (McDonald et al., 2012) . In brief, we used a two-step elution process from the aminopropyl SPE column. Column conditioning, sample loading, and column rinsing with hexane were all performed as previously described. To elute our compounds of interest, we first used 2x3mL of 30% diethyl ether in hexane to elute the sterol fraction, followed by 3mL of chloroform/methanol 23:1 to elute the oxysterol fraction. Separating the cholesterol from the oxysterols allowed us to load more of the oxysterol fraction onto the HPLC column, enhancing our detection and quantitation of trace-level oxysterols (see Figure S1 for representative chromatograms).
For mass spectrometry of LLC-PK1 and cerebellum samples, oxysterol quantification was performed relative to a d7-7-ketocholesterol (d7-7kC) internal standard that was preapared as previously reported (Xu et al., 2011) . The protein content of LLC-PK1 cells and cilia was determined using the BioRad-DC protein Assay Kit (BioRad, Hercules, CA). The average protein weight of the LLC-PK1 cells and cilia were 5.29 ± 0.62 mg/mL and 0.30 ± 0.09 mg/mL, respectively. Prior to lipid extraction, d 7 -7k-C internal standard was added to each sample (150 ng for cells; 25 ng for cilia). Lipid extraction was performed using the Folch method, in which 1 mL of 0.9% NaCl and 4 mL of Folch solution (2:1 chloroform/methanol) was added to each sample. The resulting mixture was vortexed briefly and centrifuged at 1000 rpm and 10 C for 5 min. The organic layer was recovered and dried under vacuum. The dried extracts were reconstituted in methylene chloride (300 mL for cells; 200 mL for cilia). For UHPLC-APCI-MS/MS analysis, 100 mL of LLC-PK1 cell and cilia lipid extracts was transferred into glass LC vials, dried under a stream of Argon, and reconstituted in 90% methanol with 0.1% formic acid (200 mL for LLC-PK1 cells; 50 mL for LLC-PK1 cilia). The cerebellums of P14 and P35 mice were homogenized in 5 mL of 4:1 Folch/0.9% NaCl with a blade homogenizer in the presence of d 7 -7k-C internal standard (2 mg for P14; 1 mg for P35). Following centrifugation, the organic layer was recovered and dried under vacuum. The dried extracts were reconstituted in 1 mL of methylene chloride. For UHPLC-APCI-MS/MS analysis, 50 mL of lipid extract was transferred into glass LC vials, dried under a stream of Argon and reconstituted in 50 mL of 90% methanol with 0.1% formic acid. Analysis of 7-kC and other oxysterols was performed by UHPLC-MS/MS on a triple quadrupole mass spectrometer (Sciex 6500) equipped with atmospheric pressure chemical ionization (APCI), as described previously (Fliesler et al., 2018) . Briefly, oxysterols were separated by reversed phase chromatography on a C18 column (1.7 mm, 2.1 3 100 mm, Phenomenex Kinetex) using an isocratic gradient of 90% methanol with 0.1% formic acid at a flow of 0.4 mL/min. The APCI parameters were as follows: nebulizer current, 3 mA; temperature, 350 C; curtain gas, 20 psi; ion source gas, 55 psi. Selective reaction monitoring (SRM) was used to monitor the dehydration of the oxysterol [ (Fliesler et al., 2018; Xu et al., 2011 Xu et al., , 2013 ) (see Figure S1 for representative chromatograms). The MS conditions for SRM analysis were as follows: declustering potential, 80 V; entrance potential, 10 V; collision energy, 25 V; collision cell exit potential, 20 V. Data analysis was performed with Analyst (v. 1.6.2) Quantitation Wizard. Quantitation of each oxysterol was performed against the d 7 -7k-C internal standard using a relative response factor (RRF) determined from an equal mixture of each oxysterol and d 7 -7k-C. The resulting 7k-C concentration was normalized to either protein content (for LLC-PK1 cells and cilia) or tissue weight (for cerebellums). Sterols, such as cholesterol and demosterol, were analyzed using a similar LC-MS/MS method as described previously (Fliesler et al., 2018) . Targeted mass spectrometry of oxysterols in HEK293 cells was performed as described previously using deuterated 7k-C and 7k,27-OHC standards . Targeted mass spectrometry of CNX in mouse brain homogenate used LC-MS/MS in positive electrospray ionization mode. Test samples and calibration standards in each matrix were processed by protein precipitation with two volumes of acetonitrile containing 50 ng/mL dextromethorphan internal standard (IS). The precipitated samples were vortexed, centrifuged at 6,100 x g for 30 min, diluted with two volumes 0.2% formic acid in water, and subsequently analyzed by LC-MS/MS. The analyte/IS peak area ratios versus the nominal analyte concentrations of the calibration samples in each matrix were used to fit a calibration curve by power regression. The analyte concentrations for the calibration standards and unknown samples were calculated using the established calibration equation for each matrix.
